No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract: Tisotumab Vedotin is Effective as Second- or Third-Line Therapy for Recurrent Cervical Cancer

byAstrid BradshawandAlisha Yi

July 17, 2024

in StudyGraphics

Reading Time: 1 min read

Click here to read this study in NEJM.

©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

Punjab launches AI screening program this week

2MM: AI Roundup –Lilly launches TuneLab AI drug discovery, smart wound healing bandage, and Punjab cancer screening [September 25th, 2025]

Royalty financing deepens exposure to small cell lung cancer revenues

Image-guided assessment of coronary inflammation improves cardiac risk prediction for patients without obstructive coronary artery disease

RelatedReports

Blindness and visual impairment decreasing worldwide

AI Roundup

Punjab launches AI screening program this week

September 30, 2025

AI Roundup

2MM: AI Roundup –Lilly launches TuneLab AI drug discovery, smart wound healing bandage, and Punjab cancer screening [September 25th, 2025]

September 28, 2025

Oncology

Royalty financing deepens exposure to small cell lung cancer revenues

September 8, 2025

Radiation plus hormone therapy may improve prostate cancer survival

Chronic Disease

Talazoparib and enzalutamide improve survival in metastatic castration-resistant prostate cancer

August 14, 2025

Stroke expansion following intra-arterial therapy may explain worse outcomes

Reteplase associated with improved functional outcomes in ischemic stroke patients

#VisualAbstract: Temsirolimus Combined with VAC/VI Chemotherapy Did Not Improve Clinical Outcomes of Intermediate-Risk Rhabdomyosarcoma

Extensive lymphadenectomy may not increase patient survival with esophageal cancer

Benralizumab associated with histologic response in eosinophilic esophagitis

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result